Epidemiology and Laboratory Capacity (ELC) for Prevention and Control of Emerging Infectious Diseases Cooperative Agreement

Epidemiology and Laboratory Capacity (ELC) for Prevention and Control of Emerging Infectious Diseases Cooperative Agreement is sponsored by CDC. Provides financial assistance to state, large local, and U. S.

territory and affiliate health departments to support laboratory and epidemiologic capacity, health information systems enhancements, and solutions for infectious disease outbreaks.

Epidemiology and Laboratory Capacity Epidemiology and Laboratory Capacity Program The Epidemiology and Laboratory Capacity (ELC) Program, managed by the US Centers for Disease Control and Prevention (CDC), provides critical support to public health laboratories. APHL develops guidance to support public health laboratories and shares the importance and impact of this funding.

Contact the Infectious Diseases team: [email protected] The ELC Cooperative Agreement provides cross-cutting and disease-specific funding support for public health laboratories through CDC. Cross-cutting ELC funding supports activities that strengthen epidemiology and laboratory capacity as well as health information systems for rapid disease detection and outbreak response.

In the laboratory, these funds are also used to support scientists who can work across various areas of a laboratory, staff liaisons between laboratory and epidemiology programs, laboratory equipment and maintenance contracts, courier services and electronic laboratory reporting systems. Cross-cutting funding is a mandatory expenditure of the Prevention and Public Health Fund, part of the Affordable Care Act.

Disease-specific Fundin​​​g ELC disease-specific funding supports rapid surveillance, detection and response for threats, such as foodborne diseases, seasonal influenza, vector-borne diseases, antimicrobial resistant infections and vaccine-preventable diseases. Additionally, this source provides emergency funding for emerging infectious diseases, such as COVID-19 and Zika, allowing the response to be scaled-up based on need.

Disease-specific funding is appropriated annually by Congress. APHL supports CDC and our member laboratories by providing guidance and sharing their successes.

Guidance for Public Health Laboratories Automated Extraction and PCR Platform Marketing and Support Status Nucleic Acid Amplification Platform Investigative Summary Report Nucleic Acid Extraction Platform Investigative Summary Report 6 Public Health Laboratories in 6 States Share Stories of ELC Funding Impact ELC funding protects Americans' lives by enabling laboratories to invest in crucial equipment maintenance, develop more modern reporting and testing systems and perform critical surveillance on emerging diseases.

Infectious Diseases, Laboratory Operations and Systems Advanced Molecular Detection Standing up Sequencing for SARS-CoV-2 Detecting, Sequencing and Monitoring SARS-CoV-2 Virus Variants Colorado: W​​hole Genome Sequencing Mandate-Need for Electronic Ordering Fairfax County: Modernization through Cloud Migration​ Michigan: Sharing Critical Data through the Antimicrobial Resistance Laboratory Network​ ​ Missouri: Fellowship in the Laboratory Builds Workforce Capacity​ Oregon: Streamlining the Laboratory Approach to Surveillance Reporting Wyoming: A Portal to Save the Day Wastewater Surveillance During the Pandemic—and Now?

National Wastewater Surveillance System Centers of Excellence Supporting Polio and Mpox Population Surveillance through Wastewater Testing Considerations for Implementing Wastewater Surveillance in Rural Communities Health Equity through PFAS and Wastewater Surveillance TB Cooperative Agreement Toolkit The TB Cooperative Agreement Toolkit consists of the TB Elimination Cooperative Agreement Checklist and How to Calculate Turnaround Times document designed to aid public health laboratories in the application process.

Infectious Diseases, Tuberculosis Suggested Reporting Language, Interpretation and Guidance for Lyme Disease Serologic Test Results Testing guidelines and reporting for Lyme disease standard and modified two-tier testing. This is an update to the 2021 version.

Infectious Diseases, Vector-borne Diseases HCV 2025 Meeting Report: Establishing a Road Map for Accelerated Diagnosis and Treatment of Hepatitis C Infection in the United States Summary of meeting of Hepatitis C (HCV) experts to discuss accelerating the diagnosis of current HCV infection through same-day diagnosis and treatment and viral-first testing Infectious Diseases, Viruses Bridging the Gap: How Technical Assistance is Modernizing AR Data Exchange In the fight against drug-resistant pathogens, the mandate is clear for laboratory directors and informatics leads: the speed of data exchange is as critical as the accuracy of laboratory testing.

Infectious Diseases, Antimicrobial Resistance, Disease Surveillance, Data Management, Laboratory Operations and Systems Ebola Testing Risk Assessment Template for Clinical Laboratories This template is designed to assist laboratories in the development of their risk assessment for Ebola disease. File will auto-download upon opening.

Public Health Preparedness and Response, Infectious Diseases, Emergency Preparedness and Response, Testing Methodology Ebola Testing Risk Assessment Template for Public Health Laboratories This template is designed to assist laboratories in the development of their risk assessment for the testing of orthoebolaviruses. File will auto-download upon opening.

Public Health Preparedness and Response, Infectious Diseases, Emergency Preparedness and Response, Testing Methodology